Top 10 Growth Stocks To Watch For 2019

Tech investors often flock toward high-growth companies that trade at premium valuations. However, investors shouldn’t underestimate the power of “mature” tech stocks that pay reliable dividends while trading at lower valuations. Let’s examine three of those stocks, all of which outperformed the S&P 500 this year.

Cisco

Cisco (NASDAQ:CSCO) is the world’s largest manufacturer of network routers and switches. Those are slow-growth businesses, but Cisco has been pivoting away from those products by expanding its software applications and cybersecurity businesses.

Image source: Getty Images.

Cisco’s revenue growth accelerated over the past year thanks to stronger sales of its networking hardware for enterprise campus and data center customers, rising demand for its collaboration and communications software, and the expansion of its cybersecurity portfolio through acquisitions.

Top 10 Growth Stocks To Watch For 2019: MEDIFAST INC(MED)

Advisors’ Opinion:

  • [By Lisa Levin]

    Medifast, Inc. (NYSE: MED) shares were also up, gaining 20 percent to $119 after the company reported strong Q1 results and raised its FY18 guidance.

  • [By Logan Wallace]

    MediBloc [QRC] (CURRENCY:MED) traded 11.6% lower against the US dollar during the 24 hour period ending at 20:00 PM Eastern on August 29th. One MediBloc [QRC] token can now be bought for about $0.0066 or 0.00000100 BTC on popular exchanges including Gate.io, Coinrail and Bibox. MediBloc [QRC] has a total market cap of $19.65 million and $279,707.00 worth of MediBloc [QRC] was traded on exchanges in the last 24 hours. During the last week, MediBloc [QRC] has traded 27.8% lower against the US dollar.

  • [By Joseph Griffin]

    MediBloc (CURRENCY:MED) traded 6.8% lower against the dollar during the 1-day period ending at 15:00 PM Eastern on May 27th. MediBloc has a total market cap of $73.40 million and $743,880.00 worth of MediBloc was traded on exchanges in the last 24 hours. One MediBloc token can currently be purchased for approximately $0.0247 or 0.00000339 BTC on major cryptocurrency exchanges including Bibox, Gate.io and Coinrail. During the last seven days, MediBloc has traded 8.3% higher against the dollar.

  • [By Lisa Levin]

    Medifast, Inc. (NYSE: MED) shares were also up, gaining 22 percent to $121.06 after the company reported strong Q1 results and raised its FY18 guidance.

  • [By Ethan Ryder]

    MediBloc (CURRENCY:MED) traded 3.9% lower against the U.S. dollar during the 1-day period ending at 20:00 PM E.T. on June 13th. One MediBloc token can now be purchased for $0.0083 or 0.00000131 BTC on major cryptocurrency exchanges including Coinrail, Gate.io and Bibox. During the last seven days, MediBloc has traded 36.5% lower against the U.S. dollar. MediBloc has a total market cap of $24.58 million and $216,935.00 worth of MediBloc was traded on exchanges in the last day.

  • [By Lisa Levin]

    Medifast, Inc. (NYSE: MED) shares were also up, gaining 25 percent to $124.60 after the company reported strong Q1 results and raised its FY18 guidance.

Top 10 Growth Stocks To Watch For 2019: Buffalo Wild Wings Inc.(BWLD)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Dave & Busters Entertainment tripling in value before falling back while small cap upscale gentlemen’s clubs and restaurant owner RCI Hospitality Holdings, Inc (NASDAQ: RICK) began taking off in 2016 and small cap Buffalo Wild Wings (NASDAQ: BWLD) is being acquired by Arby’s Restaurant Group:

  • [By Steve Symington]

    That’s not to say it was a quiet day for every stock on the market. With earnings season ramping up, brewing giant Anheuser-Busch InBev (NYSE:BUD) and restaurant chain Buffalo Wild Wings (NASDAQ:BWLD) served as an exercise in contrast as investors reacted to their respective quarterly reports.

Top 10 Growth Stocks To Watch For 2019: Nordstrom Inc.(JWN)

Advisors’ Opinion:

  • [By JJ Kinahan]

    The news wasn’t all good early Thursday. Results from J.C. Penney Company Inc. (NYSE: JCP) appeared to disappoint investors, who sent shares down more than 11 percent in pre-market futures trading. The company said in a press release that its overall top-line sales came in below management’s expectations, blaming cold April weather. We’re not done with retail yet. Nordstrom, Inc. (NYSE: JWN) reports after the close today.

  • [By JJ Kinahan]

    This week brings a string of retail results with reports from Walmart Inc. (NYSE: WMT) on Thursday morning and Nordstrom, Inc. (NYSE: JWN) after market close the same day. Next week, big-box retailer Target Corporation (NYSE: TGT) and home improvement retailer Lowe’s Companie, Inc. (NYSE: LOW) both report before market open on Wednesday, May 23. For a look at what else is going on across markets, check out today’s market update if you have time.

  • [By ]

    Cramer and the AAP team say today’s weakness is the opportunity they have been patiently waiting for. Their target? Nordstrom (JWN) . Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

  • [By Dan Caplinger]

    Nordstrom (NYSE:JWN) has suffered along with much of the rest of the retail industry for quite a while now, as changes in the ways shoppers like to shop have forced companies across the sector to adapt their business practices and adopt new technologies. Some had hoped that the upscale Seattle-based retailer would prove immune to those trends, but Nordstrom hasn’t escaped the resulting downward pressure. Now that it seems unlikely that the Nordstrom family will succeed in pulling off a leveraged buyout of the retailer, shareholders want to feel more confident about the future direction the company will take, especially as competitors have started to show signs of a recovery.

Top 10 Growth Stocks To Watch For 2019: Intuitive Surgical Inc.(ISRG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    OMERS ADMINISTRATION Corp lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 16.3% in the second quarter, according to the company in its most recent filing with the SEC. The fund owned 13,900 shares of the medical equipment provider’s stock after selling 2,700 shares during the quarter. OMERS ADMINISTRATION Corp’s holdings in Intuitive Surgical were worth $6,651,000 as of its most recent SEC filing.

  • [By Keith Speights]

    The No. 2 best-performing healthcare stock of the 21st century so far is Intuitive Surgical (NASDAQ:ISRG), which has generated a return of more than 9,800% since Jan. 1, 2001. Intuitive Surgical was the first company to pioneer robotic surgical systems. The company’s da Vinci robotic surgical systems were installed at over 4,400 customer sites as of the end of 2017.

  • [By Chris Hill]

    But there was more upbeat news elsewhere, with No. 3 airline United Continental (NYSE:UAL) beating on earnings and freight rail titan CSX (NASDAQ:CSX) delivering record first-quarter numbers. Also on the rapid growth train: Intuitive Surgical (NASDAQ:ISRG), whose da Vinci systems are selling at an impressive rate. And speaking of sales of tech products, the guys close out the episode by explaining why it’s a win-win that Amazon.com (NASDAQ:AMZN) and Best Buy (NYSE:BBY) are joining forces to sell smart TVs.

Top 10 Growth Stocks To Watch For 2019: TrueBlue Inc.(TBI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Russell Investments Group Ltd. grew its stake in Trueblue Inc (NYSE:TBI) by 21.2% during the first quarter, HoldingsChannel reports. The fund owned 137,178 shares of the business services provider’s stock after purchasing an additional 23,951 shares during the quarter. Russell Investments Group Ltd.’s holdings in Trueblue were worth $3,553,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    Trueblue Inc (NYSE:TBI) has received a consensus rating of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation and three have assigned a hold recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $27.50.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Trueblue (TBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Trueblue Inc (NYSE:TBI) by 18.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,550 shares of the business services provider’s stock after purchasing an additional 4,700 shares during the period. Connor Clark & Lunn Investment Management Ltd.’s holdings in Trueblue were worth $823,000 as of its most recent filing with the Securities & Exchange Commission.

Leave a Reply

Your email address will not be published. Required fields are marked *